Antidiabetic agents for the treatment of diabetes including maintenance and max doses.
Researchers conducted a retrospective chart review on patients from an endocrinology clinic who initiated a GLP-1 agonist and/or SGLT-2 inhibitor after receiving U-500 insulin for at least 3 months.
Dasiglucagon was found to be an effective and safe treatment option for severe hypoglycemia in type 1 diabetes.
Closed-loop insulin delivery may mitigate potential changes in glycemic control throughout the menstrual cycle.
Blood Glucose Meter Compatibility with Test Strips chart
Please login or register first to view this content.